Article Correctness Is Author's Responsibility: Tumor vs. immune system: A battle to decide the host’s fate

(University of Tsukuba) Researchers from the University of Tsukuba found that soluble CD155 suppresses NK cells of the innate immune system to promote tumor growth by interfering with DNAM-1. These findings could be exploited to develop novel therapies for cancer by targeting soluble CD155.